Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.
Conditions
Influenza · Acute Respiratory Viral Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Regional Budgetary Healthcare Institution "Kuvaev Ivanovo Clinical Hospital", Ivanovo, Russia
Federal State Budgetary Educational Institution of Higher Education "Kirov State Medical University" of the Ministry of Healthcare of the Russian Federation, Kirov, Russia
Contact: Study coordinator (Tatiana Chudinovskikh, MD, PhD) · Tatiana.сhudinovskikh@gmail.com · +7 (8332) 62-77-28"Medical and Diagnostic Center Veris" LLC, Kirov, Russia
State Budgetary Healthcare Institution of the City of Moscow "Consultative and Diagnostic Polyclinic № 121 of the Moscow City Department of Healthcare", Moscow, Russia
Unimed-C Jsc, Moscow, Russia
"Professor's Clinic" LLC, Perm, Russia
"Aurora MedFort" LLC, Saint Petersburg, Russia
"Eosmed" LLC, Saint Petersburg, Russia
Contact: Study coordinator (Ekaterina Polyakova, MD,PhD) · polyakova_ea@yahoo.com · +7 (812) 988-00-46"OrCli Hospital" LLC, Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "National Research Ogarev Mordovia State University", Saransk, Russia
"DNA Research Center" LLC, Saratov, Russia